A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: The only rational approach for men 50 years old and older

被引：27

作者：

Carter, HB ^{[1
]}

机构：

[1] Johns Hopkins Univ, Johns Hopkins Hosp, James Buchanan Brady Urol Inst, Sch Med,Dept Urol, Baltimore, MD 21287 USA

来源：

UROLOGY | 2000年 / 55卷 / 06期

关键词：

D O I：

10.1016/S0090-4295(00)00517-3

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：796 / 799

页数：4

共 17 条

[1]

Carter HB, 1997, RECENT ADVANCES IN PROSTATE CANCER AND BPH, P187

[2] Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease [J].

Carter, HB ;

Epstein, JI ;

Partin, AW .

UROLOGY, 1999, 53 (01) :126-130

[3] Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer [J].

Carter, HB ;

Epstein, JI ;

Chan, DW ;

Fozard, JL ;

Pearson, JD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1456-1460

[4] SELECTION OF OPTIMAL PROSTATE-SPECIFIC ANTIGEN CUTOFFS FOR EARLY DETECTION OF PROSTATE-CANCER - RECEIVER OPERATING CHARACTERISTIC CURVES [J].

CATALONA, WJ ;

HUDSON, MA ;

SCARDINO, PT ;

RICHIE, JP ;

AHMANN, FR ;

FLANIGAN, RC ;

DEKERNION, JB ;

RATLIFF, TL ;

KAVOUSSI, LR ;

DALKIN, BL ;

WATERS, WB ;

MACFARLANE, MT ;

SOUTHWICK, PC .

JOURNAL OF UROLOGY, 1994, 152 (06) :2037-2042

[5] Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease - A prospective multicenter clinical trial [J].

Catalona, WJ ;

Partin, AW ;

Slawin, KM ;

Brawer, MK ;

Flanigan, RC ;

Patel, A ;

Richie, JP ;

deKernion, JB ;

Walsh, PC ;

Scardino, PT ;

Lange, PH ;

Subong, ENP ;

Parson, RE ;

Gasior, GH ;

Loveland, KG ;

Southwick, PC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19) :1542-1547

[6] Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements [J].

Catalona, WJ ;

Smith, DS ;

Ornstein, DK .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1452-1455

[7] Serial prostate specific antigen screening for prostate cancer: A computer model evaluates competing strategies [J].

Etzioni, R ;

Cha, R ;

Cowen, ME .

JOURNAL OF UROLOGY, 1999, 162 (03) :741-748

[8] A PROSPECTIVE EVALUATION OF PLASMA PROSTATE-SPECIFIC ANTIGEN FOR DETECTION OF PROSTATIC-CANCER [J].

GANN, PH ;

HENNEKENS, CH ;

STAMPFER, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (04) :289-294

[9] Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening [J].

Humphrey, PA ;

Keetch, DW ;

Smith, DS ;

Shepherd, DL ;

Catalona, WJ .

JOURNAL OF UROLOGY, 1996, 155 (03) :816-820

[10] SERUM PROSTATE SPECIFIC ANTIGEN AS PRE-SCREENING TEST FOR PROSTATE-CANCER [J].

LABRIE, F ;

DUPONT, A ;

SUBURU, R ;

CUSAN, L ;

TREMBLAY, M ;

GOMEZ, JL ;

EMOND, J ;

STAMEY, TA ;

LANGE, PH .

JOURNAL OF UROLOGY, 1992, 147 (03) :846-852

← 1 2 →